Global In Vitro Fertilization (IVF) Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Cycle Type (Fresh IVF Cycle, Thawed IVF Cycle, Donor Egg IVF Cycles), By End User (Fertility Clinics, Hospitals And Research Centers), And By Geography - Forecasts From 2019 To 2024

Published:  Apr 2021 Report Code: KSI061611468 Pages: 126

The global In Vitro Fertilization (IVF) market is expected to grow at a CAGR of 11.24% during the forecast period to reach a total market size of US$40.348 billion by 2024, increasing from US$21.3 billion in 2018.

In vitro fertilization (IVF) involves a complex series of procedures used to treat fertility or genetic problems and assist with the conception of a child. IVF is used to treat infertility patients with Blocked or damaged fallopian tubes, male factor infertility, women with ovulation disorders, premature ovarian failure, uterine fibroids, and removed fallopian tubes, and unexplained infertility.

The global IVF services market is anticipated to exhibit significant market growth during the forecast period. The growth may be attributed to the rising male and female infertility rates due to the changing lifestyle. Growing awareness and acceptance about infertility treatment will also bolster the adoption of the In Vitro Fertilization (IVF) techniques, thus boosting the growth of the In Vitro Fertilization (IVF) market. The increasing success rate of IVF treatments will also augment the growth of the IVF market. However, the high cost of the treatment coupled with the risk associated with the In-vitro Fertilization treatment might hamper the growth of the market during the given time frame.

The Global In Vitro Fertilisation (IVF) market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key markets, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by cycle type, end-user, and geography.

Based on cycle type, the market has been segmented as Fresh IVF Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles. On the basis of end-users, the market is divided into fertility clinics, hospitals, and research centers.

Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries presents for the market players.

Major players in the In Vitro Fertilisation (IVF) market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the In Vitro Fertilisation (IVF) market.

Global In Vitro Fertilization (IVF) Market Scope:

Report Metric Details
 Market size value in 2018  US$21.3 billion
 Market size value in 2024  US$40.348 billion
 Growth Rate  CAGR of 11.24% from 2018 to 2024
 Base year  2018
 Forecast period  2019–2024
 Forecast Unit (Value)  USD Billion
 Segments covered  Cycle Type, End-User, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered Cooper Surgical, Vitrolife AB, Thermo Fisher Scientific Inc., Cook Medical, Irvine Scientific, Nikon Instruments Inc., EMD Sereno, Genea Limited, IVFtech ApS, Hamilton Thorne, Inc.
 Customization scope  Free report customization with purchase

Segmentation:

  • By Cycle Type
    • Fresh IVF Cycle
    • Thawed IVF Cycle
    • Donor Egg IVF Cycles
  • By End-User
    • Fertility clinics
    • Hospitals and research centers
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • Italy
      • Spain
      • Others
    • Middle East and Africa (MEA)
      • Israel
      • Saudi Arabia
      • Others
    • Asia Pacific (APAC)
      • China
      • Japan
      • India
      • Australia
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the In vitro fertilization (IVF) market size by 2024?
A1. The global In Vitro Fertilization (IVF) market is expected to reach a total market size of US$40.348 billion by 2024.


Q2. What is the size of global IVF market?
A2. In Vitro Fertilization market was valued at US$21.3 billion in 2018.


Q3. What are the growth prospects for the In vitro fertilization market?
A3. The In Vitro Fertilization (IVF) market is expected to grow at a CAGR of 11.24% during the forecast period.


Q4. How is the global IVF market segmented?
A4. The global IVF market has been segmented by cycle type, end-user, and geography.


Q5. What factors are anticipated to drive the In vitro fertilization (IVF) market growth?
A5. The global IVF services market growth may be attributed to the rising male and female infertility rates due to the changing lifestyle.

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. Research methodo logy
2.1. Research Design
2.2. Secondary Sources

3. Executive Summary

4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. In Vitro Fertilisation (IVF) Market by CycleType
5.1. Fresh IVF Cycle
5.2. Thawed IVF Cycle 
5.3. Donor Egg IVF Cycles 

6. In Vitro Fertilisation (IVF) Market by End User
6.1. Fertility clinics
6.2. Hospitals and research centers

7. In Vitro Fertilisation (IVF) Market by Geography
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil 
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. UK
7.3.2. Germany
7.3.3. Italy
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Israel
7.4.2. Saudi Arabia
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. Australia
7.5.5. Others

8. Competitive intelligence
8.1. Competitive Benchmarking and Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals 

9. Company Profiles
9.1. Cooper Surgical
9.2. Vitrolife AB
9.3. Thermo Fisher Scientific Inc.
9.4. Cook Medical
9.5. Irvine Scientific
9.6. Nikon Instruments Inc.
9.7. EMD Sereno
9.8. Genea Limited
9.9. IVFtech ApS
9.10. Hamilton Thorne, Inc.
 

Cooper Surgical

Vitrolife AB

Thermo Fisher Scientific Inc.

Cook Medical

Irvine Scientific

Nikon Instruments Inc.

EMD Sereno

Genea Limited

IVFtech ApS

Hamilton Thorne, Inc.

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us